These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13064837)

  • 1. Complement in disseminated (systemic) lupus erythematosus.
    ELLIOTT JA; MATHIESON DR
    AMA Arch Derm Syphilol; 1953 Aug; 68(2):119-28. PubMed ID: 13064837
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum complement levels in systemic lupus erythematosus and other diseases.
    ASHERSON GL
    Australas Ann Med; 1960 Feb; 9():57-63. PubMed ID: 13794733
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of systemic lupus erythematosus associated with disseminated intravascular coagulation (DIC); with special reference to the relation between autoimmune phenomena and coagulation-fibrinolysis reactions].
    Shinmyozu K; Ichinose A; Okada A; Maruyama I; Igata A
    Nihon Naika Gakkai Zasshi; 1983 Jul; 72(7):947-54. PubMed ID: 6663182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complement in pregnant women with systemic lupus erythematosus].
    Porcel JM
    Med Clin (Barc); 1994 Apr; 102(15):594. PubMed ID: 8189789
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus.
    Holers VM
    Arthritis Rheum; 1999 Oct; 42(10):2023-5. PubMed ID: 10524672
    [No Abstract]   [Full Text] [Related]  

  • 6. [Demonstration by complement fixation the reaction between desoxyribonucleic acid and serum of patients with disseminated lupus erythematosus].
    SELIGMANN M; MILGROM F
    C R Hebd Seances Acad Sci; 1957 Oct; 245(17):1472-5. PubMed ID: 13473214
    [No Abstract]   [Full Text] [Related]  

  • 7. "BOUND" COMPLEMENT IN THE SKIN OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS.
    KALSBEEK GL; CORMANE RH
    Lancet; 1964 Jul; 2(7352):178-80. PubMed ID: 14163132
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement and complement components in diseases of possible auto-immunological pathogenesis.
    JONSEN J; KASS E
    Acta Rheumatol Scand; 1961; 7():21-6. PubMed ID: 13790639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 11. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and systemic lupus erythematosus.
    Karp DR
    Curr Opin Rheumatol; 2005 Sep; 17(5):538-42. PubMed ID: 16093830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocomplementemia in hydralazine-associated systemic lupus erythematosus.
    Weinstein J
    Am J Med; 1978 Sep; 65(3):553-6. PubMed ID: 717423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocomplementemic vasculitis and systemic lupus erythematosus.
    Coca A; Font J; Herrero C; Gonzalez MA; Ingelmo M
    J Rheumatol; 1987 Aug; 14(4):854-5. PubMed ID: 3668995
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Lymphocyte tubuloreticular structures--disease activity correlation and sequential studies in systemic lupus erythematosus.
    Klippel JH; Grimley PM; Decker JL; Michelitch HJ
    Arthritis Rheum; 1974; 17(3):322. PubMed ID: 4363488
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement fixation with cell nuclei and DNA in lupus erythematosus.
    ROBBINS WC; HOLMAN HR; DEICHER H; KUNKEL HG
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):575-9. PubMed ID: 13505796
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic studies in patients with systemic lupus erythematosus.
    Forman MD; Kaplan D
    Prim Care; 1978 Mar; 5(1):133-42. PubMed ID: 77535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.